Abstract
Osteoarthritis (OA), a common chronic affliction amongst the elderly and athletes, is increasing every year. Due to the limited regenerative capacities of the cartilage, surgical or physical treatments have been developed for OA. The development of surgical treatment for OA has evolved from simple joint replacement to cell-based regeneration. Especially, compared with other types of stem cells, mesenchymal stem cells (bone-marrow derived stem cell (BMSC) and adipose-derived stem cell (ASC)) are well known for their high yield, excellent differentiation capacities and easy isolation, and hence are widely applied in tissue engineering. In addition, it has been known that a capability of chondrogenic differentiation of ASCs (i.e., mesenchymal stem cell population from a synovial origin) is higher than BMSCs. This review summarizes the recent clinical applications utilizing ASC and its clinical efficacy for OA treatment, estimated by applying available scoring systems. Current ASC therapy treatments in the clinical system include a direct injection of ASC supplemented with additional compounds such as platelet-rich plasma (PRP) and stromal vascular fraction (SVF) for enhancing differentiation of stem cells and the incorporation of ASC with biomaterial-based scaffolds such as fibrin and hyaluronic acid has been developed for more effective treatment than direct injection. Various scoring systems have demonstrated the clinical efficacy of ASC, and numerous results have validated the use of ASC as an OA therapy by relieving pain and improving the movement of cartilage. Furthermore, additional PRP or SVF combined with ASC have exhibited enhanced pain reduction and physiological movement of cartilage. Hence, clinical researches suggest that stem cell therapy utilizing ASC could be an effective OA treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Reference
Chung, C. and J. A. Burdick (2008) Engineering cartilage tissue. Adv Drug Deliv. Rev. 60: 243–262.
Chen, S. S., Y. H. Falcovitz, R. Schneiderman, A. Maroudas, and R. L. Sah (2001) Depth-dependent compressive properties of normal aged human femoral head articular cartilage: relationship to fixed charge density. Osteoarthritis Cartilage. 9: 561–569.
Cho, H., D. Kim, and K. Kim (2018) Engineered co-culture strategies using stem cells for facilitated chondrogenic differentiation and cartilage repair. Biotechnol. Bioprocess Eng. 23: 261–270.
Davies-Tuck, M. L., A. E. Wluka, Y Wang, A. J. Teichtahl, G. Jones, C. Ding, and F. M. Cicuttini (2008) The natural history of cartilage defects in people with knee osteoarthritis. Osteoarthritis Cartilage. 16: 337–342.
Cicuttini, F., C. Ding, A. Wluka, S. Davis, P. R. Ebeling, and G. Jones (2005) Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: a prospective study. Arthritis Rheum. 52: 2033–2039.
Cho, H., A. Lee, and K. Kim (2018) The effect of serum types on chondrogenic differentiation of adipose-derived stem cells. Biomater Res. 22: 6.
Arden, N. and M. C. Nevitt (2006) Osteoarthritis: epidemiology. Best Pract. Res. Clin. Rheumatol. 20: 3–25.
Harrell, C. R., B. S. Markovic, C. Fellabaum, A. Arsenijevic, and V. Volarevic (2019) Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed. Pharmacother. 109: 2318–2326.
Schurman, D. J. and R. L. Smith (2004) Osteoarthritis: current treatment and future prospects for surgical, medical, and biologic intervention. Clin. Orthop. Relat. Res. 427: S183–S189.
Deyle, G. D., S. C. Allison, R. L. Matekel, M. G. Ryder, J. M. Stang, D. D. Gohdes, J. P. Hutton, N. E. Henderson, and M. B. Garber (2005) Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys. Ther. 85: 1301–1317.
Kim, K., D. M. Yoon, A. G. Mikos, and F. K. Kasper (2012) Harnessing cell-biomaterial interactions for osteochondral tissue regeneration. Adv. Biochem. Eng. Biotechnol. 126: 67–104.
Memon, A. R. and J. F. Quinlan (2012) Surgical treatment of articular cartilage defects in the knee: are we winning? Adv. Orthop. 2012: 528423.
Gordey, E. E. and I. H. Wong (2018) Cartilage repair in the hip. Ann. Joint. 3: 24.
Bedi, A., B. T. Feeley, and R. J. Williams 3rd (2010) Management of articular cartilage defects of the knee. J. Bone Joint Surg. Am. 92: 994–1009.
Bernardo, M. E., D. Pagliara, and F. Locatelli (2012) Mesenchymal stromal cell therapy: a revolution in regenerative medicine? Bone Marrow Transplant. 47: 164–171.
Hwang, Y.-S., A. E. Bishop, J. M. Polak, and A. Mantalaris (2007) Enhanced in vitro chondrogenic differentiation of murine embryonic stem cells. Biotechnol. Bioprocess Eng. 12: 696–706.
Hwang, Y.-S., Y. Kang, and A. Mantalaris (2007) Directing embryonic stem cell differentiation into osteogenic chondrogenic lineage in vitro. Biotechnol. Bioprocess Eng. 12: 15–21.
Palumbo, P., F. Lombardi, G. Siragusa, M. G Cifone, B. Cinque, and M. Giuliani (2018) Methods of isolation, characterization and expansion of human adipose-derived stem cells (ascs): an overview. Int. J. Mol. Sci. 19: 1897.
Zuk, P. A., M. Zhu, H. Mizuno, J. Huang, J. W. Futrell, A. J. Katz, P. Benhaim, H. P. Lorenz, and M. H. Hedrick (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7: 211–228.
Van Pham, P., K. H. Bui, D. Q. Ngo, N. B. Vu, N. H. Truong, N. L. Phan, D. M. Le, T. D. Duong, T. D. Nguyen, V. T. Le, and N. K. Phan (2013) Activated platelet-rich plasma improves adiposederived stem cell transplantation efficiency in injured articular cartilage. Stem Cell Res. Ther. 4: 91.
Perdisa, F., N. Gostynska, A. Roffi, G. Filardo, M. Marcacci, and E. Kon (2015) Adipose-derived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells Int. 2015: 597652.
Hached, F., C. Vinatier, C. Le Visage, H. Gonde, J. Guicheux, G. Grimandi, and A. Billon-Chabaud (2017) Biomaterial-assisted cell therapy in osteoarthritis: From mesenchymal stem cells to cell encapsulation. Best Pract. Res. Clin. Rheumatol. 31: 730–745.
Pers, Y. M., M. Ruiz, D. Noel, and C. Jorgensen (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage. 23: 2027–2035.
Mengshol, J. A., M. P. Vincenti, C. I. Coon, A. Barchowsky, and C. E. Brinckerhoff (2000) Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor kB: Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43: 801–811.
Tetlow, L. C., D. J. Adlam, and D. E. Woolley (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes. Arthritis Rheum. 44: 585–594.
Tofino-Vian, M., M. I. Guillen, M. D. Perez Del Caz, A. Silvestre, and M. J. Alcaraz (2018) Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell. Physiol. Biochem. 47: 11–25.
Kim, Y. S., Y. J. Choi, D. S. Suh, D. B. Heo, Y. I. Kim, J. S. Ryu, and Y. G Koh (2015) Mesenchymal stem cell implantation in osteoarthritic knees is fibrin glue effective as a scaffold? Am. J. Sports Med. 43: 176–185.
Kim, Y. S., Y. J. Choi, S. W. Lee, O. R. Kwon, D. S. Suh, D. B. Heo, and Y. G Koh (2016) Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthritis Cartilage. 24: 237–245.
Kon, E., A. Roffi, G. Filardo, G. Tesei, and M. Marcacci (2015) Scaffold-based cartilage treatments: with or without cells? a systematic review of preclinical and clinical evidence. Arthroscopy. 31: 767–775.
Koh, Y. G, Y. J. Choi, O. R. Kwon, and Y. S. Kim (2014) Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am. J. Sports Med. 42: 1628–1637.
Spotnitz, W. D. (2014) Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective. ISRNSurg. 2014: 203943.
Francis, S. L., S. Duchi, C. Onofrillo, C. Di Bella, and P. F. M. Choong (2018) Adipose-derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int. 2018: 8947548.
Robinson, P. G, I. R. Murray, C. C. West, E. B. Goudie, L. Y. Yong, T. O. White, and R. F. LaPrade (2018) Reporting of mesenchymal stem cell preparation protocols and composition: a systematic review of the clinical orthopaedic literature. Am. J. Sports Med. 47: 991–1000.
Fellows, C. R., C. Matta, R. Zakany, I. M. Khan, and A. Mobasheri (2016) Adipose, bone marrow and synovial jointderived mesenchymal stem cells for cartilage repair. Front Genet. 7: 213.
Xie, X., Y. Wang, C. Zhao, S. Guo, S. Liu, W. Jia, R. S. Tuan, and C. Zhang (2012) Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials. 33: 7008–7018.
Haefeli, M. and A. Elfering (2006) Pain assessment. Eur. Spine J. 15: S17–S24.
Hawker, G. A., S. Mian, T. Kendzerska, and M. French (2011) Measures of adult pain: visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res. (Hoboken). 63: S240–S252.
Ibrahim, T., A. Beiri, M. Azzabi, A. J. Best, G. J. Taylor, and D. K. Menon (2007) Reliability and validity of the subjective component of the American Orthopaedic Foot and Ankle Society clinical rating scales. J. Foot Ankle Surg. 46: 65–74.
Madeley, N. J., K. J. Wing, C. Topliss, M. J. Penner, M. A. Glazebrook, and A. S. Younger (2012) Responsiveness and validity of the SF-36, ankle osteoarthritis scale, AOFAS ankle hindfoot score, and foot function index in end stage ankle arthritis. Foot Ankle Int. 33: 57–63.
Pena, F., J. Agel, and J. C. Coetzee (2007) Comparison of the MFA to the AOFAS outcome tool in a population undergoing total ankle replacement. Foot Ankle Int. 28: 788–793.
Van den Borne, M. P., N. J. Raijrnakers, J. Vanlauwe, J. Victor, S. N. de Jong, J. Bellernans, and D. B. Saris (2007) International cartilage repair society (ICRS) and oswestry macroscopic cartilage evaluation scores validated for use in autologous chondrocyte implantation (ACI) and microfracture. Osteoarthritis Cartilage. 15: 1397–1402.
Bui, K.H.-T., T. D. Duong, N. T. Nguyen, T. D. Nguyen, V. T. Le, V. T. Mai, N. L.-C. Phan, D. M. Le, N. K. Phan, and P. Van Pham (2014) Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study. Biomed. Res. Ther. 1: 2–8.
Kellgren, J. H. and J. S. Lawrence (1957) Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16: 494–502.
Emrani, P. S., J. N. Katz, C. L. Kessler, W. M. Reichmann, E. A. Wright, T. E. McAlindon, and E. Losina (2008) Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage. 16: 873–882.
Roos, E. M., H. P. Roos, L. S. Lohmander, C. Ekdahl, and B. D. Beynnon (1998) knee injury and osteoarthritis outcome score (KOOS)—development of a self-administered outcome measure. J. Orthop. Sports Phys. Ther. 28: 88–96.
Roos, E. M. and S. Toksvig-Larsen (2003) Knee injury and osteoarthritis outcome score (KOOS) — validation and comparison to the WOMAC in total knee replacement. Health Qual. Life Outcomes. 1: 17.
Collins, N. J., D. Misra, D. T. Felson, K. M. Crossley, and E. M. Roos (2011) Measures of knee function: International knee documentation committee (IKDC) subjective knee evaluation form, knee injury and osteoarthritis outcome score (KOOS), knee injury and osteoarthritis outcome score physical function short form (KOOS-PS), knee outcome survey activities of daily living scale (KOS-ADL), lysholm knee scoring scale, oxford knee score (OKS), western ontario and mcmaster universities osteoarthritis index (WOMAC), activity rating scale (ARS), and tegner activity score (TAS). Arthritis Care Res. (Hoboken). 63: S208–S228.
Gandek, B. (2015) Measurement properties of the Western Ontario and McMaster Universities Osteoarthritis Index: a systematic review. Arthritis Care Res. (Hoboken). 67: 216–229.
Faschingbauer, M., M. Kasparek, P. Schadler, A. Trubrich, S. Urlaub, and F. Boettner (2017) Predictive values of WOMAC, KOOS, and SF-12 score for knee arthroplasty: data from the OAI. Knee Surg. Sports Traumatol. Arthrosc. 25: 3333–3339.
McConnell, S., P. Kolopack, and A. M. Davis (2001) The western ontario and mcmaster universities osteoarthritis index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 45: 453–461.
Dougados, M. (2004) Monitoring osteoarthritis progression and therapy. Osteoarthritis Cartilage. 12: S55–S60.
Higgins, L. D., M. K. Taylor, D. Park, N. Ghodadra, M. Marchant, R. Pietrobon, and C. Cook (2007) Reliability and validity of the international knee documentation committee (IKDC) Subjective Knee Form. Joint Bone Spine. 74: 594–599.
Anderson, A. F., J. J. Irrgang, M. S. Kocher, B. J. Mann, and J. J. Harrast (2006) The international knee documentation committee subjective knee evaluation form: normative data. Am. J. Sports Med. 34: 128–135.
Ebrahimzadeh, M. H., H. Makhmalbaf, F. Golhasani-Keshtan, S. Rabani, and A. Birjandinejad (2015) The international knee documentation committee (IKDC) subjective short form: a validity and reliability study. Knee Surg. Sports Traumatol. Arthrosc. 23: 3163–3167.
Briggs, K. K., M. S. Kocher, W. G. Rodkey, and J. R. Steadman (2006) Reliability, validity, and responsiveness of the Lysholm knee score and Tegner activity scale for patients with meniscal injury of the knee. J. Bone Joint Surg. Am. 88: 698–705.
Hambly, K. (2011) The use of the Tegner Activity Scale for articular cartilage repair of the knee: a systematic review. Knee Surg. Sports Traumatol. Arthrosc. 19: 604–614.
Fodor, P. B. and S. G. Paulseth (2016) Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg. J. 36: 229–236.
Ronn, K., N. Reischl, E. Gautier, and M. Jacobi (2011) Current surgical treatment of knee osteoarthritis. Arthritis. 2011: 454873.
Kon, E., A. Gobbi, G. Filardo, M. Delcogliano, S. Zaffagnini, and M. Marcacci (2009) Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years. Am. J. Sports Med. 37: 33–41.
Spakova, T., J. Rosocha, M. Lacko, D. Harvanova, and A. Gharaibeh (2012) Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am. J. Phys. Med. Rehabil. 91: 411–417.
Ayhan, E., H. Kesmezacar, and I. Akgun (2014) Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J. Orthop. 5: 351–361.
Burke, J., M. Hunter, R. Kolhe, C. Isales, M. Hamrick, and S. Fulzele (2016) Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis. Clin. Transl. Med. 5: 27.
Bansal, H., K. Comella, J. Leon, P. Verma, D. Agrawal, P. Koka, and T. Ichim (2017) Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J. Transl. Med. 15: 141.
Hudetz, D., I. Boric, E. Rod, Z. Jelec, A. Radic, T. Vrdoljak, A. Skelin, G. Lauc, I. Trbojevic-Akmacic, M. Plecko, O. Polasek, and D. Primorac (2017) The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel). 8: 270.
Jo, C. H., Y. G. Lee, W. H. Shin, H. Kim, J. W. Chai, E. C. Jeong, J. E. Kim, H. Shim, J. S. Shin, I. S. Shin, J. C. Ra, S. Oh, and K. S. Yoon (2014) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of- concept clinical trial. Stem Cells. 32: 1254–1266.
Jo, C. H., J. W. Chai, E. C. Jeong, S. Oh, J. S. Shin, H. Shim, and K. S. Yoon (2017) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am. J. Sports Med. 45: 2774–2783.
Orozco, L., A. Munar, R. Soler, M. Alberca, F. Soler, M. Huguet, J. Sentis, A. Sanchez, and J. Garcia-Sancho (2013) Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 95: 1535–1541.
Sekiya, I., T. Muneta, M. Horie, and H. Koga (2015) Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin. Orthop. Relat. Res. 473: 2316–2326.
Pers, Y. M., L. Rackwitz, R. Ferreira, O. Pullig, C. Delfour, F. Barry, L. Sensebe, L. Casteilla, S. Fleury, P. Bourin, D. Noel, F. Canovas, C. Cyteval, G. Lisignoli, J. Schrauth, D. Haddad, S. Domergue, U. Noeth, C. Jorgensen, and A. Consortium (2016) Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase i dose-escalation trial. Stem Cells Transl. Med. 5: 847–856.
Koh, Y. G. and Y. J. Choi (2012) Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 19: 902–907.
Koh, Y. G, Y. J. Choi, S. K. Kwon, Y. S. Kim, and J. E. Yeo (2015) Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 23: 1308–1316.
Kim, Y. S. and Y. G. Koh (2016) Injection of mesenchymal stem cells as a supplementary strategy of marrow stimulation improves cartilage regeneration after lateral sliding calcaneal osteotomy for varus ankle osteoarthritis: clinical and second-look arthroscopic results. Arthroscopy. 32: 878–889.
Kim, Y. S., H. J. Lee, Y. J. Choi, Y. I. Kim, and Y. G Koh (2014) Does an injection of a stromal vascular fraction containing adipose-derived mesenchymal stem cells influence the outcomes of marrow stimulation in osteochondral lesions of the talus? a clinical and magnetic resonance imaging study. Am. J. Sports Med. 42: 2424–2434.
Kim, Y. S., E. H. Park, Y. C. Kim, and Y. G. Koh (2013) Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am. J. Sports Med. 41: 1090–1099.
Hangody, L., G. Kish, L. Modis, I. Szerb, L. Gaspar, Z. Dioszegi, and Z. Kendik (2001) Mosaicplasty for the treatment of osteochondritis dissecans of the talus: two to seven year results in 36 patients. Foot Ankle Int. 22: 552–558.
van Buul, G. M., W. L. Koevoet, N. Kops, P. K. Bos, J. A. Verhaar, H. Weinans, M. R. Bernsen, and G. J. van Osch (2011) Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 39: 2362–2370.
Kuroda, K., T. Kabata, K. Hayashi, T. Maeda, Y. Kajino, S. Iwai, K. Fujita, K. Hasegawa, D. Inoue, N. Sugimoto, and H. Tsuchiya (2015) The paracrine effect of adipose-derived stem cells inhibits osteoarthritis progression. BMC Musculoskelet Disord. 16: 236.
Veronesi, F., M. Maglio, M. Tschon, N. N. Aldini, and M. Fini (2014) Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J. Biomed. Mater. Res. A. 102: 2448–2466.
Kim, Y. S., Y. J. Choi, and Y. G. Koh (2015) Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes. Am. J. Sports Med. 43: 2293–2301.
Park, E. H., H. S. Lim, S. Lee, K. Roh, K. W. Seo, K. S. Kang, and K. Shin (2018) Intravenous infusion of umbilical cord bloodderived mesenchymal stem cells in rheumatoid arthritis: a phase la clinical trial. Stem Cells Transl. Med. 7: 636–642.
Alvaro-Gracia, J. M., J. A. Jover, R. Garcia-Vicuna, L. Carreno, A. Alonso, S. Marsal, F. Blanco, V. M. Martinez-Taboada, P. Taylor, C. Martin-Martin, O. DelaRosa, I. Tagarro, and F. Diaz-Gonzalez (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann. Rheum. Dis. 76: 196–202.
Pak, J. (2011) Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J. Med. Case Rep. 5: 296.
Pak, J., J. J. Chang, J. H. Lee, and S. H. Lee (2013) Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet Disord. 14: 337.
Pak, J., J. H. Lee, K. S. Park, B. C. Jeong, and S. H. Lee (2016) Regeneration of cartilage in human knee osteoarthritis with autologous adipose tissue-derived stem cells and autologous extracellular matrix. Biores Open Access. 5: 192–200.
Acknowledgement
This research work was supported by NRF grant funded by the Korea government (MSIP) (NRF-2017R1C1B1003665).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Rights and permissions
About this article
Cite this article
Cho, H., Kim, H., Kim, Y.G. et al. Recent Clinical Trials in Adipose-derived Stem Cell Mediated Osteoarthritis Treatment. Biotechnol Bioproc E 24, 839–853 (2019). https://doi.org/10.1007/s12257-019-0255-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-019-0255-7